Connect with us

Business

HempMeds Mexico, A Subsidiary Of Medical Marijuana Inc (OTCMKTS:MJNA), Inaugurates Mexico City Office

Published

on

HempMeds Mexico, a subsidiary of Medical Marijuana Inc (OTCMKTS:MJNA), has inaugurated Mexico City Office. President of HempMeds Latin America and Mexico, Raul Elizalde, said the company is pleased to inaugurate a new office in Mexico City. He said the new office will strengthen its position in the nation. The company already operates several offices in Monterrey.

Guides the public on CBD

The newly inaugurated office in Mexico City will guide the public about its CBD products. It will also envisage the benefits of these products over other CBD products in the market. The company will also educate the users on how to discuss with medical professionals to maximize the use of CBD for therapeutic purposes.

The market for medical cannabis

The demand for medical cannabis in Mexico is estimated at $47.3 million in the year 2018. Following the legalization, the market for recreational and medical cannabis is expected to reach over $1 billion in Mexico by the year 2024.

Promotes access to CBD products

HempMeds Mexico is supporting several non-profit organizations to promote access to cannabidiol products. It is also working with the Mexican Government to establish a process so that patients get easy access to RSHO-X (Real Scientific Hemp Oil-X). HempMeds is the first to obtain a COFEPRIS central government import permit for RSHO-X. The company will collaborate with the general public, health professionals, and local authorities to promote the entire industry.

Dr. Stuart Titus, Chief Executive Officer of Medical Marijuana, said the company has put in significant efforts to introduce CBD to the Mexican Market. He said the new office in Mexico City will help the company to expand the business across the nation. It will educate the public and Mexican citizens about the differences between marijuana and hemp.

2019 is a great year for Medical Marijuana

Medical Marijuana improved sales in 2019. The company received a Bronze Stevie Award for continued efforts in the CBD space. It’s subsidiary – Kannaway is putting in efforts to establish its footprint in Japan. Kannaway has exhibited excellent performance in healthcare products and services. It helped the company to receive Silver Golden Bridge Award.

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.

FEATURED STORIES

Business22 hours ago

Planet 13 Holdings Inc. (OTCMKTS:PLNHF) Signs Purchase Agreement To Acquire 45,000 Sq. ft. Facility In Nevada

Post Views: 108 Planet 13 Holdings Inc. (OTCMKTS:PLNHF) announced the signing of an asset purchase agreement subject to which it...

Business2 days ago

Indus Holdings Inc. (OTCMKTS:INDXF) Terminates Its Pending $20 million Acquisition Agreement Of W Vapes Assets

Post Views: 145 Indus Holdings Inc. (OTCMKTS:INDXF) announced termination of its impending acquisition of W Vapes assets that was announced...

Business2 days ago

1933 Industries Inc. (OTCMKTS:TGIFF) Introduces Pre-roll Joints And Smokable Cannabis Flower In Nevada

Post Views: 133 1933 Industries Inc. (OTCMKTS:TGIFF) announced addition of pre-joint rolls and high-quality smokable flowers to its growing consumer...

Business3 days ago

Cannabis Pharmaceuticals Inc. (OTCMKTS:CNBX) Initiates Expansion Of Its Cannabinoid Diagnostic Platform Tests In Europe

Post Views: 61 Cannabis Pharmaceuticals Inc. (OTCMKTS:CNBX) commenced expansion in the European markets to offer cancer patients tailored cannabinoid treatment...

INDUSTRIAL HEMP3 days ago

Generex Biotechnology Corporation (OTCMKTS:GNBT) Submits Pre-IND For Ii-Key-SARS-CoV-2 Vaccine To The FDA

Post Views: 198 Generex Biotechnology Corporation (OTCMKTS:GNBT) submitted a Pre-IND update to the FDA outlining its proposed Phase I/II clinical...

Business6 days ago

cbdMD Inc. (NYSEAMERICAN:YCBD) Protecting Its CBD Technologies Through Patents and expands Partnership With Bellator MMA

Post Views: 310 cbdMD Inc. (NYSEAMERICAN:YCBD) announced an extension of the exclusive Official CBD marketing partnership with ViacomCBS’s wholly-owned subsidiary...